SOD2 and acute myeloid leukemia: Further studies revealed that inactivation of the NRF2 pathway leads to reduced production of antioxidants (e.g., SOD2), which shifts the ratio of GSH/GSSG to the oxidized form, thereby increasing AML cellular chemosensitivity (Niu et al., 2021).